Lonza keeps adding on as it looks to beef up biologics offering, tacking on nearly $1B in expansions in EU, US

Pierre-Alain Ruffieux

Amid a flurry of expansion activity, CDMO Lonza is continuing to beef up its manufacturing plants both in its native Switzerland and in the US. The newest plan? A $935 million outlay to build new sites in Visp and Portsmouth, NH, to help grow...

Click to view original post